Nebbioso et al. pointed out that UVI5008 was an epigenetic modifier that inhibited HDAC, DNMT, and sirtuins, which efficiently induced selective death of cancer cells and exerted its activity in genetic mouse models of human breast cancer and several human tumor xenografts. Here, HDAC9 is linked to cancer.